WHO issues emergency use validation for Pfizer vaccine, BioNTech COVID-19



ANI |
Updated:
January 1, 2021 4:11 AM IST

Geneva [Switzerland], January 1 (ANI / Sputnik): The World Health Organization said on Thursday it had issued an emergency validation of the use of the coronavirus vaccine developed by Pfizer and BioNTech, the first since the beginning of the pandemic.
“The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer / BioNTech vaccine the first to receive emergency validation from the WHO since the outbreak began a year ago,” the WHO said. in a statement. .

The WHO decision allowed UNICEF and the Pan American Health Organization to procure the vaccine for distribution to countries in need.
“WHO and our partners are working day and night to evaluate other vaccines that have met safety and efficacy standards. We encourage even more developers to come forward for review and evaluation. It is vital to ensure the critical supply needed to serve all the surrounding countries. Mariangela Simao, said the WHO’s assistant director-general for access to medicines and health products.
The WHO declared the outbreak of COVID-19 a pandemic on March 11. To date, more than 83.1 million people have been infected with the coronavirus worldwide, with more than 1.81 million deaths, according to Johns Hopkins University. (ANI / Sputnik)

Source